| |
| |
|
| Insider
Information: |
Alton Gregg H |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,846 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,731,983 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,846 |
|
|
| Total
Value |
$3,731,983 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,710 |
55,406 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-03-12 |
4 |
D |
$44.04 |
$106,269 |
D/D |
(2,413) |
52,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-04-01 |
4 |
OE |
$8.94 |
$26,828 |
D/D |
3,000 |
55,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-04-01 |
4 |
S |
$44.50 |
$358,486 |
D/D |
(8,000) |
47,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-05-01 |
4 |
S |
$45.95 |
$367,600 |
D/D |
(8,000) |
42,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-05-01 |
4 |
OE |
$8.94 |
$26,828 |
D/D |
3,000 |
50,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-06-01 |
4 |
S |
$43.15 |
$129,450 |
D/D |
(3,000) |
42,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-06-01 |
4 |
OE |
$8.94 |
$26,828 |
D/D |
3,000 |
45,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-06-03 |
4 |
S |
$45.00 |
$225,000 |
D/D |
(5,000) |
37,993 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General CounselOfficer |
• – – |
2005-07-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,354 |
|
- |
|
360 Records found
|
|
Page 15 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
